Europe

J&J vaccine and thrombosis: EU begins check

The EMA will check reports that those vaccinated against the  with the J&J drug in the United States have experienced side effects.





The European Medicines Agency (EMA) will check information about possible severe side effects of the Johnson & Johnson before the drug is actually used in the . This was reported by the EMA on Friday, April 9.

As specified in the agency’s message, we are talking about the occurrence of thrombosis after . The vaccine of the American pharmaceutical company Johnson & Johnson was approved by the European Commission for use in the EU in March this year.

Reports of side effects from J&J in the US

Earlier, on April 8, it was reported that in the US state of North Carolina, the vaccination center against COVID-19 was temporarily closed after several people showed side effects after being vaccinated with the J&J vaccine. A day earlier, the same measures were followed in the state of Denver, where patients after vaccination with this drug complained of dizziness and nausea.

J&J Vaccine Benefits

Unlike most other vaccines, the J&J vaccine only needs to be given once, so more people can get access to the vaccine. In addition, the J&J vaccine does not require ultra-low temperatures to be stored and transported. Like the AstraZeneca and Sputnik V vaccines, J&J is a vector vaccine.

The U.S. Food and Drug Administration (FDA) registered the J&J vaccine in February 2021. The results of phase 3 clinical trials indicate that this drug reduces the risk of moderate to severe coronavirus by 66% after four weeks of vaccination.


Google News

Leave a Reply

Your email address will not be published. Required fields are marked *